HOXA9 and rectum adenocarcinoma: Tumor tissues of colon adenocarcinoma (COAD), esophageal carcinoma (ESCA), head and neck cancer (HNSC), kidney renal papillary cell carcinoma (KIRP), liver hepatocellular carcinoma (LIHC), lung squamous cell carcinoma (LUSC), prostate adenocarcinoma (PRAD), rectal adenocarcinoma (READ), and stomach adenocarcinoma (STAD) exhibited increased expression of HOXA9 compared to that of the solid normal samples (p value < 0.05) (Fig. 3).